Restoration of tumor suppressor functions by small-molecule inhibitors.
Over the last decades, accumulating data have advanced our understanding of the mechanism of action of tumor suppressor proteins and therapeutic strategies to restore tumor suppressor pathways have emerged as a promising approach for cancer therapy. Based on our recent findings on bridging integrator-1 (BIN1), we outline potential advantages and disadvantages of chemical activation of tumor suppressors.
Université Paris Diderot ; INSERM UMRS1162 ; Paris, France.
Slovénie
S
Pyndiah
Department of Biochemistry and Molecular Biology; Medical College of Georgia; Georgia Regents University Cancer Center ; Augusta, GA, USA.
Daitoku
D
Sakamuro
BIN1; RB1; p53; small-molecule inhibitor; tumor suppressor